骨质疏松性骨折围手术期的药物治疗

Drug therapy of osteoporotic fractures during perioperative period

骨质疏松性骨折是一个全球性的骨骼健康问题,患病人群广泛且早期症状隐伏,严重危害老年人群的健康,骨折是其最严重的并发症。骨质疏松性骨折手术治疗难度大,疗效常不令人满意,因此,在积极手术治疗骨折的同时,一定要重视骨质疏松的药物治疗。骨质疏松性骨折围手术期使用抗骨吸收,以及补充活性维生素D3和钙剂,可以为骨质疏松性骨折进行各种手术准备较好的骨质基础,同时促进骨愈合,预防再次骨折的发生。本文针对骨质疏松性骨折围手术期的药物治疗进行讨论。

Osteoporotic fractures are bone health problem worldwide, with an extensive patient population and the latent early symptom, especially hazarding the health of the elderly people. The fracture is the most severe complication. The operation for treatment of osteoporotic fractures is difficult, and the result is commonly unsatisfactory. Thus, we should pay attention to the drug therapy of osteoporosis when we perform operation in the treatment of fractures. The drugs of anti-bone resorption, activating vitamin Da ,and calcium used during the perioperative period of osteoporotic fractures can provide a better bone foundation, promote bone healing, and prevent the occurrence of re-fractures. This paper discusses about the drug therapy of osteoporotic fractures during perioperative period.